Clas Sonesson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial.
Journal: Movement disorders clinical practice
Published: November 04, 2024
First-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers.
Journal: Clinical pharmacology in drug development
Published: March 08, 2021
A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers.
Journal: Pharmacology research & perspectives
Published: November 16, 2020
(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 02, 2020
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 18, 2019
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 14, 2019
Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trial.
Journal: NPJ Parkinson's disease
Published: June 08, 2018
Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease.
Journal: Journal of Huntington's disease
Published: February 27, 2018
In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery.
Journal: ACS chemical neuroscience
Published: December 21, 2016
A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.
Journal: European journal of medicinal chemistry
Published: June 23, 2013
Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
Journal: European journal of medicinal chemistry
Published: December 12, 2012
Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach.
Journal: Journal of medicinal chemistry
Published: October 10, 2012
Last Updated: 09/26/2026